Kuros Biosciences AG (KURN.SW) SIX
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.06B |
| Enterprise Value | 1.04B |
| P/E Ratio | 118.9 |
| PEG Ratio | 0.14 |
| Price/Sales Ratio | 6.12 |
| Price/Book Ratio | 11.79 |
| Enterprise/Revenue | 6.14 |
| Enterprise/EBITDA | 73.73 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.05 |
| Operating Margin | 0.06 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 121.3M |
| Revenue/Share | 3.52 |
| Gross Profit | 104.79M |
| EBITDA | 10.13M |
| Net Income | 2.12M |
| Diluted EPS | 0.05 |
Balance Sheet
| Total Cash | 7.85M |
| Total Cash/Share | 0.2 |
| Total Debt | 11.01M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 1.87 |
| Book Value Per Share | 1.82 |
Price History
| 52-Week Change | -16.85 |
| 52-Week High | 34.2 |
| 52-Week Low | 17.69 |
| Moving Average 50 Days | 20.8 |
| Moving Average 200 Days | 24.04 |
Statistics
| Average Volume | 188,510 |
| Shares Outstanding | 39.44M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 217:200 |
| Last Split Date | October 08, 2020 |
AD
